Virologic Response to Tipranavir-Ritonavir or Darunavir-Ritonavir Based Regimens in Antiretroviral Therapy Experienced HIV-1 Patients: A Meta-Analysis and Meta-Regression of Randomized Controlled Clinical Trials

BACKGROUND: The development of tipranavir and darunavir, second generation non-peptidic HIV protease inhibitors, with marked improved resistance profiles, has opened a new perspective on the treatment of antiretroviral therapy (ART) experienced HIV patients with poor viral load control. The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Berhan, Asres, Berhan, Yifru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617230/
https://www.ncbi.nlm.nih.gov/pubmed/23593314
http://dx.doi.org/10.1371/journal.pone.0060814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617230/
https://www.ncbi.nlm.nih.gov/pubmed/23593314
http://dx.doi.org/10.1371/journal.pone.0060814

Ejemplares similares